The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...
Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
Stocktwits on MSN
Genmab stock slips after discontinuing further development of cancer drug developed with ...
The decision to discontinue further clinical development of Acasunlimab does not impact Genmab’s full‑year 2025 financial ...
Russia claims a breakthrough in cancer treatment with a personalized mRNA vaccine, designed to train the immune system to target and destroy cancer cells. However, detailed scientific data, and ...
Several genetic factors are associated with cancer manifestations, including DNA mutations, deletion, fusions, and translocation. It is imperative to understand the process of tumorigenesis to ...
This review was designed by Professor Xiaoling Song and Professor Biao Jiang and written by Pr. Xiaoling Song and a Ph.D. student, Yifan Wu (Shanghai Institute for Advanced Immunochemical Studies, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. On the regional level, as the Human Development Index ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する